Smith SM - Search Results

1

A novel endocrinology-based wellness program to reduce medication expenditures and improve glycemic outcomes.

Evans JG, Sutton DR, Dajani LH, Magee JS, Silva RA, Roura MF, Wadud K, Purcell JA, Travaglini S, Segel SA, Sultan S, Roffman MS, Ayad SS, Borja-Hart NL, Smith SM. Evans JG, et al. Among authors: smith sm. Diabetes Metab Syndr. 2013 Apr-Jun;7(2):87-90. doi: 10.1016/j.dsx.2013.02.016. Epub 2013 Mar 22. Diabetes Metab Syndr. 2013. PMID: 23680247

2

Potential benefits of warfarin monitoring by a clinical pharmacist in a long term care facility.

Motycka C, Kesgen C, Smith SM, Alvarez E, Jones K. Motycka C, et al. Among authors: smith sm. J Thromb Thrombolysis. 2012 Feb;33(2):173-7. doi: 10.1007/s11239-011-0642-1. J Thromb Thrombolysis. 2012. PMID: 21964972

3

Intensive blood pressure lowering reduces adverse cardiovascular outcomes among patients with high-normal glucose: An analysis from the Systolic Blood Pressure Intervention Trial database.

Gong Y, Smith SM, Handberg EM, Pepine CJ, Cooper-DeHoff RM. Gong Y, et al. Among authors: smith sm. J Clin Hypertens (Greenwich). 2018 Apr;20(4):620-624. doi: 10.1111/jch.13247. Epub 2018 Mar 13. J Clin Hypertens (Greenwich). 2018. PMID: 29532983 Free PMC article. Clinical Trial.

4

SGLT2 inhibitors and kidney outcomes in the real world.

Smith SM. Smith SM. BMJ. 2020 Apr 29;369:m1584. doi: 10.1136/bmj.m1584. BMJ. 2020. PMID: 32349997 No abstract available.

5

Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes.

Dawwas GK, Smith SM, Park H. Dawwas GK, et al. Among authors: smith sm. Diabetes Obes Metab. 2019 Jan;21(1):28-36. doi: 10.1111/dom.13477. Epub 2018 Aug 16. Diabetes Obes Metab. 2019. PMID: 30039524

6

Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists.

Dawwas GK, Smith SM, Park H. Dawwas GK, et al. Among authors: smith sm. Cardiovasc Diabetol. 2018 Jul 17;17(1):102. doi: 10.1186/s12933-018-0746-4. Cardiovasc Diabetol. 2018. PMID: 30016946 Free PMC article.

7

Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials.

Tang H, Kimmel SE, Smith SM, Cusi K, Shi W, Gurka M, Winterstein AG, Guo J. Tang H, et al. Among authors: smith sm. Diabetes Care. 2022 Apr 1;45(4):1007-1012. doi: 10.2337/dc21-1722. Diabetes Care. 2022. PMID: 35349656 Review.

8

Medication Adherence-Still the Holy Grail.

Cooper-DeHoff RM, Smith SM. Cooper-DeHoff RM, et al. Among authors: smith sm. J Am Heart Assoc. 2023 Feb 21;12(4):e028688. doi: 10.1161/JAHA.122.028688. Epub 2023 Feb 3. J Am Heart Assoc. 2023. PMID: 36734419 Free PMC article. No abstract available.

9

Twelve-year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States.

Dawwas GK, Leonard CE, Garg M, Vouri SM, Smith SM, Flory JH, Genuardi MV, Park H. Dawwas GK, et al. Among authors: smith sm. Diabetes Obes Metab. 2020 Apr;22(4):705-710. doi: 10.1111/dom.13949. Epub 2020 Jan 19. Diabetes Obes Metab. 2020. PMID: 31903713

10

Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic disease.

Bovio JA, Smith SM, Gums JG. Bovio JA, et al. Among authors: smith sm. Ann Pharmacother. 2011 May;45(5):603-14. doi: 10.1345/aph.1P644. Epub 2011 May 3. Ann Pharmacother. 2011. PMID: 21540406 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,435 results

Search Page